Publications by authors named "Rudolf Huber"

Claim this Profile
A
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status.
Lyudmila Bazhenova, J G Hodgson, D Ross Camidge, Corey J Langer, Rudolf M Huber

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.
Alessandro Brunelli, Georgia Hardavella, Rudolf M Huber, Thierry Berghmans, Armin Frille

Eur J Cardiothorac Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.
Alessandro Brunelli, Georgia Hardavella, Rudolf M Huber, Thierry Berghmans, Armin Frille

Eur Respir J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Sample Adequacy for Comprehensive Biomarker Testing of Bronchoscopic Biopsies: An American Association of Bronchology and Interventional Pulmonology and International Association for the Study of Lung Cancer Clinical Practice Guideline.
Udit Chaddha, Abhinav Agrawal, Uzair Ghori, Fayez Kheir, Labib Debiane, Rudolf M Huber

J Thorac Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer Screening Program Quality Indicators-Review and Recommendations: An International Association for the Study of Lung Cancer Delphi Process Study.
Martin C Tammemägi, Andrea Borondy-Kitts, John K Field, Claudia I Henschke, Anant Mohan, Rudolf M Huber

J Thorac Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Response to the Letter to the Editor: "Quality Performance Indicators for Lung Cancer Screening: Towards the Next Levels?".
Martin C Tammemägi, Andrea Borondy-Kitts, John F Field, Anant Mohan, Anna Kerpel-Fronius, Rudolf Huber

J Thorac Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer.
Rudolf M Huber, Diego Kauffmann-Guerrero

Curr Opin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the Letters to the Editor by Jing Peng and Colleagues and by Lauren C Leiman Regarding the Manuscript "Terminology Issues in Screening and Early Detection of Lung Cancer-International Association for the Study of Lung Cancer Early Detection and Screening Committee Expert Group Recommendations".
Rudolf M Huber, Stephen Lam, Milena Cavic, Haval Balata, Andrea Borondy Kitts

J Thorac Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the International Association for the Study of Lung Cancer Early Detection and Screening Committee: Terminology Issues in Screening and Early Detection of Lung Cancer-International Association for the Study of Lung Cancer Early Detection and Screening Committee Expert Group Recommendations.
Rudolf M Huber, Milena Cavic, Haval Balata, Andrea Borondy Kitts, John K Field

J Thorac Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspective on Management of Low-Dose Computed Tomography Findings on Low-Dose Computed Tomography Examinations for Lung Cancer Screening. From the International Association for the Study of Lung Cancer Early Detection and Screening Committee.
Claudia Henschke, Rudolf Huber, Long Jiang, Dawei Yang, Milena Cavic

J Thorac Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant therapy with immune checkpoint inhibitors in operable nonsmall cell lung cancer.
Rudolf M Huber

Curr Opin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective.
Clemens Aigner, Hasan Batirel, Rudolf M Huber, David R Jones, Alan D L Sihoe

Eur Respir Rev· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Early detection of lung cancer - current status and implementation scenarios].
Rudolf M Huber

Pneumologie· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice.
Julia Walter, Caroline Moeller, Blerina Resuli, Diego Kauffmann-Guerrero, Farkhad Manapov, Rudolf M Huber

J Cancer Res Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version].
Wolfgang Schütte, Sylvia Gütz, Wiebke Nehls, Torsten Gerriet Blum, Wolfgang Brückl, Rudolf M Huber

Pneumologie· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory + NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials.
Scott N Gettinger, Rudolf M Huber, Dong-Wan Kim, Lyudmila Bazhenova, Karin Holmskov Hansen

JTO Clin Res Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report.
Rudolf M Huber, Milena Cavic, Anna Kerpel-Fronius, Lucia Viola, John Field

J Thorac Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer Screening in Persons Who Never Smoked Has to be Evaluated-A Response to Letter to the Editor.
Anna Kerpel-Fronius, Martin C Tammemägi, Milena Cavic, Rudolf M Huber, , Rudolf Huber

J Thorac Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report.
Anna Kerpel-Fronius, Martin Tammemägi, Milena Cavic, Claudia Henschke, Long Jiang, Rudolf M Huber

J Thorac Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT).
Amanda Tufman, Jens Neumann, Farkhad Manapov, Laura Sellmer, Andreas Jung, Rudolf Maria Huber

Lung Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care.
Michaela Schunk, Ursula Berger, Lien Le, Eva Rehfuess, Larissa Schwarzkopf, Rudolf Maria Huber

ERJ Open Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: a pragmatic fast-track randomised controlled trial (BreathEase).
Michaela Schunk, Lien Le, Zulfiya Syunyaeva, Birgit Haberland, Susanne Tänzler, Rudolf Maria Huber

Eur Respir J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New developments in locally advanced nonsmall cell lung cancer.
Rudolf M Huber, Diego Kauffmann-Guerrero, Hans Hoffmann, Michael Flentje

Eur Respir Rev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer.
Diego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber

Drugs· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary intestinal lymphangiectasia in an adult patient: A case report and review of literature.
Rudolf Huber, Georg Semmler, Alexander Mayr, Felix Offner, Christian Datz

World J Gastroenterol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis